Equities researchers at HC Wainwright raised their FY2025 earnings per share estimates for shares of Integra Resources in a ...
Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) had its price target trimmed by HC Wainwright from $15.00 to $11.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results